Prelude Growth Partners — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
OneSkin develops topical skincare products built around OS-01, a proprietary peptide the company says reduces cellular senescence in skin to address visible signs of aging such as wrinkles and hyperpigmentation.
BiotechDirect to ConsumerLongevitySan Francisco, US
Carolina Reis de Oliveira(Executive Officer, Director)inAlessandra Zonari(OneSkin Co-founder & Chief Scientific Officer)inCarolina Reis Oliveira(OneSkin Co-founder & CEO)inAlessandra Zonari Scheel(Founder)inMariana Boroni, PhD(Co-founder)Juliana Carvalho, PhD(Co-founder)
Co-investorsAble PartnersMetaplanetPLUS CapitalSelva VenturesUnilever VenturesSOSV
Perelel makes doctor-formulated vitamin and supplement packs tailored to specific stages of women's hormonal lives, including trying to conceive, pregnancy trimesters, postpartum, motherhood, and perimenopause.
Direct to ConsumerFemTechWellness & FitnessSanta Monica, US
Victoria Thain Gioia(Executive Officer, Director, Promoter)inAlexandra Taylor(Executive Officer, Director, Promoter)Banafsheh Bayati(Co-Founder (board-certified OB/GYN))
BoardRachel Harris(Director)inNeda Daneshzadeh(Director)
Co-investorsSelva VenturesUnilever VenturesPRELUDEWillow Growth Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.